January, 2012

PL Developments’ “Kick-Off” for Charity

The month of February is a great time of year for one of America’s favorite pastimes: the Super Bowl! With what everyone called Déjà Blue, it was the New York Giants and the New England Patriots once again this year. In the spirit of the big game, PL Developments hosted its own “tailgating” party, but to make it more meaningful and generous, all those employees who participated brought in some sort of canned or dry goods to donate to a local charity. This is common practice for PLD with the thought that it is always a good time to give back to the community. The effort was spearheaded by PLD co-worker Kathy McCabe and she was delighted to deliver two boxes and a bag full of food to St. Vincent de Paul in Lindenhurst, NY.        

December, 2011

PL Developments gives back through humanitarian mission

Earlier this year PL Developments participated in a humanitarian medical mission to bring drugs and medical attention to a remote village of Garifuna people in Honduras. This endeavor came to fruition by working with Project CHIMES (California Honduras Institute for Medical and Education Support).

Project CHIMES is a nonprofit organization. They are devoted to raising money to assist native peoples in Central and South America gain access to basic medical services. One of these native groups, the Garifuna people, is a fascinating ethnic group with their own language and culture intact since the 17th century. Their story is an extraordinary tale of survival, adaption, and endurance. PL Developments donated OTC medicine, all of which they needed and was dispensed immediately. According to Evan Singer, Executive Vice President of PL Developments, “Helping deliver important medicines to those in need is part of the core values of PL Developments.”

Headquartered in Westbury, New York, PL Developments is a leading supplier of over-the-counter, FDA approved products in the analgesic, gastrointestinal, cough/cold, sleep/motion, and eye care categories. PL Developments Manufacturing, located in Miami, Florida, is an integrated single source for oral dosage development and manufacturing of OTC pharmaceutical and nutritional products. PL Developments will continue to lead the industry with innovation, excellence, and commitment to their mission of dedication to the well being of their customers, consumers, employees, and community.

 

 

 

December, 2011

Pharmaceutical Company honors employees for dedicated years of service

PL Developments recognizes employees for reaching service milestones.

Each year employees of PL Developments are honored for reaching noteworthy years of service. Earlier this month the workers of five, ten, and fifteen years of continued employment were celebrated at a company luncheon.

For the year 2011, 24 employees reached the five year milestone, 13 more reached ten years and another two reached the remarkable 15 year milestone. One recipient, Kathy McCabe, Senior Buyer, stated, “It has been an exciting journey working here for the past 15 years. I still can’t believe it when I think back of where we were as a company when I started, compared to what we have become today and where we are still going!” Sandra Villatoro, Quality Control Supervisor, added, “These 15 years with the company have been a learning process and I have gained much experience.”

Evan Singer, Executive Vice President of PL Developments, stated “The passion and dedication of each PLD associate drives our company’s success. Our yearly recognition of those associates who have served PLD for five, ten, fifteen years is always a special event which celebrates the peoPLe of PL Developments.” PL Developments’ success is due in large part to the amazing people who are working together, and the experience, knowledge, and passion each possess and pass on to their co-workers.

Headquartered in Westbury, New York, PL Developments is a leading supplier of over-the-counter, FDA approved products in the analgesic, gastrointestinal, cough/cold, sleep/motion, and eye care categories. PL Developments Manufacturing, located in Miami, Florida, is an integrated single source for oral dosage development and manufacturing of OTC pharmaceutical and nutritional products. PL Developments will continue to lead the industry with innovation, excellence, and commitment to their mission of dedication to the well being of their customers, consumers, employees, and community.

 

October 7, 2011

Avéma Pharma Solutions is now PL Developments

This is a special time in our company’s history as we continue to expand our brand. Avéma Pharma Solutions, our Miami Manufacturing facility has changed its name to PL Developments (our parent company headquarters in Westbury, NY). The name change to PL developments will define the shift that is taking place at the heart of PL Developments as it positions itself to be a leading provider of healthcare products in the industry.

As a company, we have seen much change over the past 23 years; however, what has not changed at PL Developments is our commitment to providing quality products, exceptional customer service and passion for our people.

I’m incredibly excited about this journey and truly believe the best of PL Developments is yet to come.

Regards,

Mitch Singer

September 2, 2011

PL Developments announces the addition of seven new ANDA products to their product portfolio.

Westbury, NY. – September 2, 2011 – PL Developments is pleased to announce the addition of seven new ANDA products to their line. It is expected that all of these new FDA approved OTC items will be approved for sale and to ship in the first half of 2012. These products will be available to be marketed under store brand to PL Developments customers. New products offered will include:

-   Lansoprazole 15mg (Compare to: Prevacid® 24HR) Powerful Proton Pump Inhibitor (PPI) that helps prevent acid that causes heartburn.

-   Fexofenadine 60mg & Fexofenadine 180mg (Compare to: Allegra® 12hr & 24hr) – Treats both indoor and outdoor allergy symptoms

-   Famotidine 10 mg (Compare to: Original Strength Pepcid® AC) and Famotidine 20mg (Compare to: Maximum Strength Pepcid® AC) –Histamine 2 blocker. Prevents & Relieves Heartburn due to Acid Indigestion.

-   Ranitidine 75mg ( Compare to: Zantac® 75) and Ranitidine 150mg (Compare to: Zantac® 150) – Prevents & Relieves Heartburn associated with Acid Indigestion, Sour Stomach, Foods & Beverages.

For more information email vkerof@pldevelopments.com

April 4, 2011

PL Developments acquires exclusive sales and distribution rights to OTC store brand versions of ZEGERID OTC™
from Par Pharmaceutical

Westbury, NY.  – April 4, 2011  – PL Developments today announced that it has acquired the exclusive rights to sell and distribute store brand OTC versions of Omeprazole/Sodium Bicarbonate capsules, the generic version of Schering Plough Healthcare Products Inc.’s Zegerid OTC™.  Par Pharmaceutical currently has approval for the Rx product and has filed for the OTC version.  Upon FDA approval and upon favorable resolution of IP litigation, PL Developments will market Omeprazole/Sodium Bicarbonate OTC under store brand to its customers. Zegerid is the first immediate-release oral proton pump inhibitor (PPI) to be approved for the U.S. market.  Zegerid OTC™ is indicated for the relief of symptoms associated with frequent heartburn associated with gastroesophagael reflux disease.  Schering Plough Healthcare Products received approval for the Rx-to-OTC switch of this drug in late 2009 and launched March 2010.  Rx Zegerid had annual sales of approximately $218 million in 2009 and Zegerid OTC™is forecasted to reach sales of $100 million by 2012, according to data provided by IMS.  Store brand sales within the gastrointestinal category grew 11.9% outpacing National Brand growth by 8.7%, based on IRI data 52wk ending Jan 2011.

PL Developments President and CEO Mitch Singer stated, “Our partnership with Par and investment in a first to file generic Omeprazole/Sodium Bicarbonate OTC is an exciting example of PL Developments’ dedication to bringing valuable products and technologies to our retail partners.”

About Par Pharmaceutical Companies, Inc.

Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company.  Through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures, and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For a press release and other company information, visit www.parpharm.com

Vinima Kerof, Vice President, Marketing

(516) 986-1699

Email: vkerof@pldevelopments.com

December 20, 2010

PL Developments launches private label ADVIL® PM LIQUID GELS® Westbury, NY

PL Developments announces new product launch.

Westbury, NY- December 20, 2010- PL Developments announced earlier this month that it will now be selling a generic version of Advil® PM Liquid Gels®. PL Developments will be the first company to market a generic version of this product. Advil® PM Liquid Gels® are used to treat pain along with occasional sleeplessness.

Director of Marketing for PL Developments, Vinima Kerof, stated, “PL Developments remains committed to providing our customers with new and innovative products for the private label market.” PL Developments is also the first company to market a generic version of Advil® Liquid Gels®.

Headquartered in Westbury, New York, and Miami, Florida, PL Developments is a leading supplier of over-the-counter, FDA approved products in the analgesic, gastrointestinal and the cough/cold, sleep/motion categories. Avéma Pharma Solutions (A Division of PL Developments) is an integrated single source for solid dosage development and manufacturing of OTC pharmaceutical and nutritional products. PL Developments will continue to lead the industry with innovation, excellence, and commitment to their mission of quality products and the well-being of their customers, consumers, employees, and community.

March 2010

PL Developments Got Talent Westbury, NY

As part of an effort to encourage individual expression, PL Developments has introduced a creative opportunity for the PLD family. The PLD’s Got Talent Collage is being hosted by the Creative Services department. This project is made up of small canvases that in the end will be assembled to create one large painting. Each PL Developments employee is encouraged to get their creative juices flowing and design their own canvas. Supervisor Michele DiVincenzo said, “We wanted to create an opportunity for every department to come and express themselves. It functions as a bonding experience. Office interaction like this brings us together and adds to the foundation of what makes us a family here at PL Developments.”

Employees are able to display their creativity in this unique way. Purchasing Assistant, Paola Heelan said, “The PLD’s Got Talent Collage was a creative way to express our individual personalities and emotions. It was a form of stress relief as well as relaxation. I found it very interesting to see each individual’s personal expression as they painted their piece.”

Not only has this opportunity brought the office together, but it has allowed unsuspecting people to develop a new hobby. Buyer Jessica Suray discovered her passion for painting while participating in the PLD’s Got Talent Collage. “I have been in the painting room three times already and the experience has been excellent for me. I went to buy supplies to paint at home since this.”

PL Developments’ commitment to promote creative expression does not stop here. The Journey Forward Art Project inspires creativity from the local community, inviting high schools and universities to create art using PL Developments’ pharmaceuticals as their subject matter. The project encourages the passion for individuality in the students.  The artwork is used to enhance the office environment while exposing employees, customers, and visitors to the talented youth of the community.

The PLD’s Got Talent Collage and the Journey Forward Art Project are just a couple of ways PL Developments hopes to inspire their employees and community. The collage will be displayed in the PL Developments Lobby once completed. It will represent a piece of everyone and act as a reminder to all of the camaraderie and unity PL Developments prides itself on.

Headquartered in Westbury, New York, and Miami, Florida, PL Developments is a leading supplier of over-the-counter, FDA approved products in the analgesic, gastrointestinal, cough/cold, sleep/motion, and eye care categories. Avéma Pharma Solutions (A Division of PL Developments) is an integrated single source for oral dosage development and manufacturing of OTC pharmaceutical and nutritional products. PL Developments will continue to lead the industry with innovation, excellence, and commitment to their mission of dedication to the well-being of their customers, consumers, employees, and community. Visit them at www.pldevelopments.com